Literature DB >> 15670624

Cells, scaffolds, and molecules for myocardial tissue engineering.

Jonathan Leor1, Yoram Amsalem, Smadar Cohen.   

Abstract

Unlike heart valves or blood vessels, heart muscle has no replacement alternatives. The most challenging goal in the field of cardiovascular tissue engineering is the creation/ regeneration of an engineered heart muscle. Recent advances in methods of stem cell isolation, culture in bioreactors, and the synthesis of bioactive materials promise to create engineered cardiac tissue ex vivo. At the same time, new approaches are conceived that explore ways to induce tissue regeneration after injury. The purpose of our review is to describe the principles, status, and challenges of myocardial tissue engineering with emphasize on the concept of in situ cardiac tissue engineering and regeneration.

Mesh:

Substances:

Year:  2004        PMID: 15670624     DOI: 10.1016/j.pharmthera.2004.10.003

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  59 in total

1.  Novel biodegradable, biomimetic and functionalised polymer scaffolds to prevent expansion of post-infarct left ventricular remodelling.

Authors:  Caterina Cristallini; Mariacristina Gagliardi; Niccoletta Barbani; Daniela Giannessi; Giulio D Guerra
Journal:  J Mater Sci Mater Med       Date:  2011-12-06       Impact factor: 3.896

Review 2.  Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.

Authors:  James D Richardson; Adam J Nelson; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley; Peter J Psaltis
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

3.  Synthetic matrices to serve as niches for muscle cell transplantation.

Authors:  Sarah Fernandes; Shannon Kuklok; Joe McGonigle; Hans Reinecke; Charles E Murry
Journal:  Cells Tissues Organs       Date:  2011-10-14       Impact factor: 2.481

Review 4.  Custom design of the cardiac microenvironment with biomaterials.

Authors:  Michael E Davis; Patrick C H Hsieh; Alan J Grodzinsky; Richard T Lee
Journal:  Circ Res       Date:  2005-07-08       Impact factor: 17.367

Review 5.  Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction.

Authors:  Kathy Yuan Ye; Lauren Deems Black
Journal:  J Cardiovasc Transl Res       Date:  2011-08-05       Impact factor: 4.132

Review 6.  Engineering Functional Cardiac Tissues for Regenerative Medicine Applications.

Authors:  Martin L Tomov; Carmen J Gil; Alexander Cetnar; Andrea S Theus; Bryanna J Lima; Joy E Nish; Holly D Bauser-Heaton; Vahid Serpooshan
Journal:  Curr Cardiol Rep       Date:  2019-08-01       Impact factor: 2.931

7.  Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering.

Authors:  Sonya B Seif-Naraghi; Michael A Salvatore; Pam J Schup-Magoffin; Diane P Hu; Karen L Christman
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

Review 8.  Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review.

Authors:  Marwa Tallawi; Elisabetta Rosellini; Niccoletta Barbani; Maria Grazia Cascone; Ranjana Rai; Guillaume Saint-Pierre; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2015-07-06       Impact factor: 4.118

9.  Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering.

Authors:  Jennifer M Singelyn; Jessica A DeQuach; Sonya B Seif-Naraghi; Robert B Littlefield; Pamela J Schup-Magoffin; Karen L Christman
Journal:  Biomaterials       Date:  2009-07-15       Impact factor: 12.479

Review 10.  Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices.

Authors:  Jennifer M Singelyn; Karen L Christman
Journal:  J Cardiovasc Transl Res       Date:  2010-07-15       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.